Consolidated Statements of Shareholders’ Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2020	$ 2,249,695	$ (49,530)	$ 10	$ 799,549	$ (55,590)	$ (74,124)	$ 1,524,878	$ 6,060	$ (618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	12,536			12,536
Repurchase of common stock	(1,515)					(1,515)
Changes in comprehensive income (loss)	86								86
Issuance of common stock and warrants, net	375,332		1	375,331
Net income (loss)	(472,569)						(472,569)
Ending balance at Dec. 31, 2021	2,114,035		11	1,131,826		(75,639)	1,058,369		(532)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Convertible debt conversions	2,706			2,706
Share-based compensation	11,483			11,483
Repurchase of common stock	(2,359)					(2,359)
Changes in comprehensive income (loss)	(64)								(64)
Issuance of common stock and warrants, net	0		0	0
Net income (loss)	(554,150)						(554,150)
Ending balance at Dec. 31, 2022	1,571,651		11	1,146,015		(77,998)	504,219		(596)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Convertible debt conversions	300			300
Share-based compensation	11,963			11,963
Repurchase of common stock	(2,637)					(2,637)
Changes in comprehensive income (loss)	529								529
Net income (loss)	(447,464)						(447,464)
Ending balance at Dec. 31, 2023	$ 1,134,342		$ 11	$ 1,158,278		$ (80,635)	$ 56,755		$ (67)